Colin Kelley is an Operating Partner for Merida Capital Partners. He is also a board member of LeafLine Labs, one of two licensed producers and distributors of medical cannabis in Minnesota.
Prior to Merida, Kelley served as the Chief Financial Officer and Chief Operating Officer of LeafLine Labs. Additionally, he has held management roles at Dun & Bradstreet, Investors Bank & Trust, Wind River Capital Management, and Fresenius Medical Care. He has consulted to the SAP Business Incubator and the Civilian Research & Development Fund. Kelley earned his BSBA in Management and Finance from Bryant University in Rhode Island.